Optiscan Imaging Limited engages in the development, manufacture, and commercialization of endomicroscopic digital imaging technology solutions for medical, translational, and pre-clinical applications in Australia, Germany, and Internationally. It offers InVivage, an intra-oral digital hand-held confocal endomicroscope for oral cancer screening and/or surgical margin determination; and ViewnVivo, a miniaturized in vivo imaging device that offers single-cell 3D live microscopic imaging. The company was founded in 1994 and is headquartered in Mulgrave, Australia.
Stock data | 2025 | Change |
---|---|---|
Price | $0.10587348741039677 | N/A |
Market Cap | $88.44M | N/A |
Shares Outstanding | 835.34M | N/A |
Employees | 0 | N/A |